Patent No. Europe EP 93100041.8 Granted EP/0550400 Austria EP 93100041.8 Granted EP/0550400 Belgium EP 93100041.8 Granted EP/0550400 France EP 93100041.8 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Luxembourg EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 *United States 07/077,528
Appears in 2 contracts
Samples: Subscription and License Agreement (OncoMed Pharmaceuticals Inc), Subscription and License Agreement (OncoMed Pharmaceuticals Inc)
Patent No. Europe EP 93100041.8 86900983.7 Granted EP/0550400 EP/0211047 Austria EP 93100041.8 86900983.7 Granted EP/0550400 EP /0211047 Belgium EP 93100041.8 86900983.7 Granted EP/0550400 EP/0211047 France EP 93100041.8 86900983.7 Granted EP/0550400 Germany EP 93100041.8 Granted EP/0550400 Italy EP 93100041.8 Granted EP/0550400 Luxembourg EP 93100041.8 Granted EP/0550400 Netherlands EP 93100041.8 Granted EP/0550400 Sweden EP 93100041.8 Granted EP/0550400 Switzerland/Liechtenstein EP 93100041.8 Granted EP/0550400 United Kingdom EP 93100041.8 Granted EP/0550400 *United States 07/077,528EP/0211047
Appears in 2 contracts
Samples: License Agreement (Affimed Therapeutics B.V.), License Agreement (Affimed Therapeutics B.V.)
Patent No. Austria EP 86900983.7 Granted EP/0211047 Belgium EP 86900983.7 Granted EP/0211047 Europe EP 93100041.8 86900983.7 Granted EP/0550400 Austria EP/0211047 Finland 863891 Granted 00000 Xxxxxx EP 93100041.8 86900983.7 Granted EP/0550400 Belgium EP 93100041.8 Granted EP/0550400 France EP 93100041.8 Granted EP/0550400 EP/0211047 Germany EP 93100041.8 86900983.7 Granted EP/0550400 P3689598.9-08 Italy EP 93100041.8 86900983.7 Granted EP/0550400 EP/0000000 Japan 500818/86 Granted 0000000 Xxxxx 094753/94 Granted 2121896 Luxembourg EP 93100041.8 86900983.7 Granted EP/0550400 EP/0211047 Netherlands EP 93100041.8 86900983.7 Granted EP/0550400 Sweden EP/0211047 Norway 863806 Granted 000000 Xxxxxx EP 93100041.8 86900983.7 Granted EP/0550400 Switzerland/EP/0211047 Switzerland/ Liechtenstein EP 93100041.8 86900983.7 Granted EP/0550400 EP/0211047 United Kingdom EP 93100041.8 86900983.7 Granted EP/0550400 *United States 07/077,528EP/0211047
Appears in 1 contract
Samples: Non Exclusive License Agreement (Viventia Biotech Inc.)
